Aarti Industries Limited

NSE AARTIIND.NS

Aarti Industries Limited Total Non-Current Liabilities for the year ending March 31, 2024: USD 209.64 M

Aarti Industries Limited Total Non-Current Liabilities is USD 209.64 M for the year ending March 31, 2024, a 96.47% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Aarti Industries Limited Total Non-Current Liabilities for the year ending March 31, 2023 was USD 106.70 M, a -42.97% change year over year.
  • Aarti Industries Limited Total Non-Current Liabilities for the year ending March 31, 2022 was USD 187.10 M, a -20.65% change year over year.
  • Aarti Industries Limited Total Non-Current Liabilities for the year ending March 31, 2021 was USD 235.80 M, a 32.34% change year over year.
  • Aarti Industries Limited Total Non-Current Liabilities for the year ending March 31, 2020 was USD 178.18 M, a 2.24% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
NSE: AARTIIND.NS

Aarti Industries Limited

CEO Mr. Suyog Kalyanji Kotecha
IPO Date July 1, 2002
Location India
Headquarters 71, Udyog Kshetra
Employees 6,100
Sector Health Care
Industries
Description

Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Similar companies

DEEPAKNTR.NS

Deepak Nitrite Limited

USD 27.05

0.71%

PIIND.NS

PI Industries Limited

USD 40.01

2.00%

ATUL.NS

Atul Ltd

USD 77.84

2.00%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 41.96

0.53%

VINATIORGA.NS

Vinati Organics Limited

USD 18.82

-1.09%

StockViz Staff

January 16, 2025

Any question? Send us an email